Navigation Links
Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data
Date:5/18/2009

eSeal(R) Hemostasis Patch.

About MEDRAD, INC.

MEDRAD, INC. develops, markets and services medical devices used to diagnose and treat disease. Its product offerings include fluid injection systems for radiology and cardiology, endovascular devices for the safe treatment of cardiovascular disease, magnetic resonance-compatible accessories and equipment services. MEDRAD's total 2008 revenues were over $600 million. The company's world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is a business of Bayer Medical Care. More company information is available at www.medrad.com.

Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.

Cautionary statement regarding forward-looking statements.

Certain statements in this press release that are neither reported financial results nor other historical information are forward-looking statements, including but not limited to, statements that are predictions of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can b
'/>"/>

SOURCE MEDRAD
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CDC Analysis Finds Unique Social and Behavior Intervention Helps Reduce MRSA Rates Up to 62% in Study Hospitals
2. Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers
3. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
4. Unique Hearing Aid Receives Patent Protection
5. Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab
6. ANX-201 Demonstrates a Unique Resistance Profile in Preclinical Tests
7. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
8. Taking a Hard-Line Approach to Cardiovascular Risks in the Diabetes Patient
9. Task Force Recommends Using Aspirin to Prevent Cardiovascular Disease When the Benefits Outweigh the Harms
10. VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
11. Physicians Health Study II Finds No Magic Bullet for Preventing Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... -- Biomedical Research Laboratories (BRL) ( www.brlscience.com ) announced ... 2014 Inc. 500 list of America,s fastest-growing companies. ... prestigious list and ranked among the most successful companies ... Laboratories, CEO. "Today,s announcement represents a major milestone for ... work and talent of our team. BRL has a ...
(Date:8/26/2014)... Mass. , Aug. 26, 2014 Acelleron Medical ... Eatontown, N.J ., is expanding.  Acelleron, a ... to form a new division, Acelleron Maternal Health & Wellness ... clients by providing a full range of resources for pregnant ... has been named the director of maternal wellness. Vecchi, the ...
(Date:8/26/2014)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and its associated pain, ... advance an immunotherapy targeting WNT1-Inducible Signaling Protein-1 (WISP1) ... more than 100,000 Americans. As this disease progresses, ... lose the ability to breathe, leading ultimately to ...
Breaking Medicine Technology:Biomedical Research Laboratories Named to Inc. 500 List of America's Fastest-Growing Companies 2Suzanne Vecchi Named Director of Newly Acquired Acelleron Maternal Health & Wellness 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 3
... DATATRAK International, Inc. (OTCQX: DATA), a technology and services ... trials industry, today announced that it has been awarded ... Organization (CRO) in India, with which the Company had ... order to execute a Phase II study for the ...
... 8, 2011 Vanda Pharmaceuticals Inc. (Nasdaq: ... has granted orphan drug designation for tasimelteon, an oral ... for Non-24-Hour Sleep/Wake Disorder (N24HSWD) in blind individuals with ... the designation that the Committee for Orphan Medicinal Products ...
Cached Medicine Technology:DATATRAK Awarded First Study With Kreara Solutions 2DATATRAK Awarded First Study With Kreara Solutions 3Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon 2Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon 3Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon 4
(Date:8/26/2014)... Hearing aids are not always covered ... holders to determine what their hearing care benefits are. ... health plans and has published benefit details on their website ... , The following is a list of insurances or agencies ... NYSHIP/ NYS Empire Plan - Hearing Aid Benefit is $1500 ...
(Date:8/26/2014)... August 27, 2014 Emerging and established ... and useful to those they serve – which includes ... blog at http://www.PerWickstrom.com and read his latest ... Leaders Maintain their Edge.” , “Leadership is ... and can therefore be assumed,” commented Per Wickstrom, who ...
(Date:8/26/2014)... August 27, 2014 There are a ... however the reality is cruel. Some people, especially ladies ... may not save enough money to be affluent. Today, ... delighted to announce its new catalog, Flash Deals (also ... bags, outdoor accessories and more from this company are ...
(Date:8/26/2014)... 27, 2014 Atlanta Hearing Associates ... Hearing Associates has expanded its professional staff to 6 audiologists. ... Stephanie Collins . Atlanta Hearing Associates prides itself ... display a passionate commitment to patient needs and keep themselves ... loss treatments. The practice has grown from 1 to 4 ...
(Date:8/26/2014)... (PRWEB) August 27, 2014 Private ... custom labeled nutritional dietary supplements and products has ... their 33rd annual Inc. 500|5000 list. This exclusive ... marks the second consecutive year for Private Label ... Dell, Yelp, GoPro, Bridger, Tough Mudder, Bowlmor and ...
Breaking Medicine News(10 mins):Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 2Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 3Health News:Per Wickstrom’s Latest Blog Post Provides 10 Tips to Help Leaders Maintain their Edge 2Health News:Become a Rich Person Right Away By Taking Advantage Of Fecbek.com's Flash Deals 2Health News:Atlanta Hearing Associates Needs New Audiologists to Its Professional Staff 2Health News:Atlanta Hearing Associates Needs New Audiologists to Its Professional Staff 3Health News:Private Label Nutraceuticals Honored by Inc. 5000 as One of Today’s Fastest Growing Private Companies in America with Three-Year Sales Growth of 620% 2Health News:Private Label Nutraceuticals Honored by Inc. 5000 as One of Today’s Fastest Growing Private Companies in America with Three-Year Sales Growth of 620% 3Health News:Private Label Nutraceuticals Honored by Inc. 5000 as One of Today’s Fastest Growing Private Companies in America with Three-Year Sales Growth of 620% 4
... poses dangers, researchers say , , TUESDAY, Dec. 23 (HealthDay ... adults in the United States combine over-the-counter medications with ... for potentially dangerous interactions, a new survey finds. , ... for more than 175,000 emergency department visits for adverse ...
... doesn,t fund procedure , , TUESDAY, Dec. 23 (HealthDay ... each year, because their states don,t cover the procedure ... case to be made that circumcisions can protect our ... of public policy at the University of California, Los ...
... major tissue damage or surgical intervention is an important ... established therapeutic measure for severe liver diseases, it would ... the regenerative process and if they depend on the ... The group led by Prof. Schlaak from the Department ...
... It might be possible to grow human blood ... new study at The Ohio State University Medical Center. ... issue of the journal Experimental Hematology , might ... and in quantities that can ease the chronically tight ...
... the mutation faced higher odds of heart attack, death, study ... variation can make younger heart attack patients more prone to ... receive the anti-clotting drug Plavix, researchers report. , The study ... The Lancet . , Plavix plus low-dose aspirin are often ...
... LANSING, Mich. Only 3 percent of kids, meals ... the first study to examine the nutrient quality of ... Michigan State University,s Sharon Hoerr, a food science and ... teamed up with economist Sharon O,Donnell and pediatrician Jason ...
Cached Medicine News:Health News:Drug Combinations Putting Seniors at Risk 2Health News:Drug Combinations Putting Seniors at Risk 3Health News:Drug Combinations Putting Seniors at Risk 4Health News:Circumcision Rates Too Low 2Health News:Molecular events involved in liver regeneration 2Health News:Bioreactors might solve blood-platelet supply problems 2Health News:Gene Ups Risk for Those on Blood-Thinner Plavix 2Health News:Gene Ups Risk for Those on Blood-Thinner Plavix 3Health News:Nutritious fast-food kids' meals are scarce, researchers find 2
Determination of Prothrombin Time (PT)by STA Analyzers (ISI~1.8).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
The CA method used on the Dade Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of calcium in serum....
The PHOS method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of phosphorus in serum....
For the quantitative in vitro determination of Magnesium in serum, plasma and urine...
Medicine Products: